Your browser is no longer supported. Please, upgrade your browser.
SOLY Soliton, Inc. weekly Stock Chart
Soliton, Inc.
Index- P/E- EPS (ttm)-1.05 Insider Own64.39% Shs Outstand15.88M Perf Week0.53%
Market Cap211.68M Forward P/E- EPS next Y- Insider Trans- Shs Float5.66M Perf Month4.14%
Income-12.40M PEG- EPS next Q- Inst Own3.60% Short Float18.82% Perf Quarter-12.59%
Sales- P/S- EPS this Y-29.10% Inst Trans337.47% Short Ratio1.01 Perf Half Y70.52%
Book/sh0.73 P/B18.26 EPS next Y- ROA-229.80% Target Price- Perf Year-
Cash/sh0.71 P/C18.90 EPS next 5Y- ROE225.30% 52W Range4.12 - 29.00 Perf YTD173.72%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-54.03% Beta-
Dividend %- Quick Ratio5.90 Sales past 5Y- Gross Margin- 52W Low223.54% ATR0.98
Employees7 Current Ratio5.90 Sales Q/Q- Oper. Margin- RSI (14)51.75 Volatility7.33% 7.18%
OptionableNo Debt/Eq0.00 EPS Q/Q87.20% Profit Margin- Rel Volume0.49 Prev Close13.61
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.06M Price13.33
Recom- SMA202.55% SMA504.24% SMA20015.25% Volume523,552 Change-2.06%
Sep-19-19 08:45AM  Soliton Begins Treatments In Proof-Of-Concept Trial For Keloid Scars PR Newswire
Sep-17-19 11:58AM  Do Institutions Own Soliton, Inc. (NASDAQ:SOLY) Shares? Simply Wall St.
08:00AM  Soliton Completes Trial Enrollment and Conducts Initial Site Training to Start Keloid Trial PR Newswire
Sep-10-19 08:00AM  Soliton Announces Site Selected for Clinical Trial to Treat Fibrotic Scars PR Newswire
Sep-09-19 08:00AM  Soliton Releases Letter to Shareholders PR Newswire
Sep-04-19 08:00AM  Soliton Announces IRB Approval for Keloid Trial PR Newswire
Aug-29-19 08:00AM  Soliton to Initiate POC Clinical Trials to Treat Fibrotic Scars Using Acoustic Shockwaves; Estimated Market Size of $10 Billion by 2025 PR Newswire
Aug-26-19 08:00AM  Soliton Engages argodesign in Preparation of Commercial Launch of its RAP Device PR Newswire
Aug-20-19 08:00AM  Soliton Announces Positive Results Demonstrated from Longer RAP Treatment PR Newswire +14.01%
Aug-16-19 08:00AM  Dr. Michael Kaminer Presented Soliton RAP for Cellulite at Key Dermatology Conference PR Newswire +7.61%
Aug-14-19 08:00AM  Soliton Treats First Patients in Pivotal Cellulite Trial PR Newswire
Aug-12-19 08:00AM  Soliton Announces Patient Recruitment Has Begun for Pivotal Cellulite Trial PR Newswire +20.98%
Aug-06-19 08:00AM  Soliton Completes Site Enrollment and Conducts Initial Site Training to Start Pivotal Cellulite Trial PR Newswire
Aug-05-19 08:00AM  Soliton Partners with Clear Dermatology and Aesthetics Center to Advance Pivotal Cellulite Trial PR Newswire
Aug-01-19 08:00AM  Soliton Announces Global Nasdaq Partner Sanmina Delivers RAP Device to More Effectively Target Cellulite Reduction for Pivotal Trial PR Newswire
Jul-29-19 08:00AM  Soliton Announces IRB Approval PR Newswire
Jul-25-19 08:00AM  Soliton Enlists Chicago Cosmetic Surgery and Dermatology to Advance Pivotal Cellulite Trial PR Newswire -8.97%
Jul-23-19 08:00AM  Soliton's FDA Cleared Device is Granted Key Patent PR Newswire
Jul-15-19 03:22PM  Why Soliton Stock Is Falling Today Motley Fool -13.48%
08:00AM  Soliton Announces Positive 26-week Cellulite Clinical Trial Results Demonstrate Long-Term Improvement PR Newswire
Jul-10-19 08:00AM  Soliton Expands Clinical Trial Sites to include SkinCare Physicians PR Newswire
Jul-09-19 11:10AM  A Look At Benzinga Pro's Most-Searched Tickers For July 9, 2019 Benzinga -9.19%
Jul-08-19 08:00AM  Soliton to Announce Cellulite Trial Data for 26-Week Period on July 15, 2019 PR Newswire +61.85%
Jul-02-19 08:00AM  Soliton Announces Filing of Form S-1 Registering the Shares Issued in Private Placement at $14.00 per Unit PR Newswire -9.48%
Jul-01-19 08:00AM  Soliton Partners with Capital Laser and Skin Care to Advance Pivotal Cellulite Trial PR Newswire -5.99%
Jun-28-19 02:19PM  18 Stocks Joining The Russell Indices Benzinga
08:00AM  Soliton's Inclusion in the Russell 2000 and 3000 will be Effective After the Close of the Market Today PR Newswire
Jun-25-19 08:00AM  Soliton Engages CRO to begin Pivotal Cellulite Trial PR Newswire
Jun-18-19 01:03PM  Soliton to be Added to the Russell 2000 and 3000 Indexes on June 28, 2019 PR Newswire
Jun-17-19 09:15AM  Soliton Announces $9.45 Million Private Placement PR Newswire +16.36%
Jun-12-19 08:30AM  Soliton Announces Long-Term Cellulite Trial Results to be Presented at The Aesthetics Show on July 11-14, 2019 PR Newswire -10.40%
Jun-11-19 08:30AM  Soliton Confirms Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance for Today at 4:30 PM ET PR Newswire
Jun-05-19 08:00AM  Soliton Announces Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance PR Newswire -6.00%
Jun-04-19 08:00AM  Soliton Announces Significant Discovery of Acoustic Subcision for Treatment of Cellulite PR Newswire +22.05%
May-30-19 04:26PM  Why Soliton's Shares Went on a Roller Coaster Ride Today Motley Fool -7.79%
May-29-19 12:06PM  Soliton Tattoo Removal Device: SOLY Stock Skyrockets on FDA Approval InvestorPlace +42.62%
10:39AM  Companies to Watch: Canada Goose misses, Intel unveils new chips, Soliton soars on FDA approval Yahoo Finance
10:30AM  Medtech Firm Extends 300% Surge on Cellulite, Tattoo Device Hope Bloomberg
10:00AM  Stock Market Tumbles At Open, Breaks Below Key Levels Investor's Business Daily
09:33AM  Soliton Soars a Second Day After FDA Approves Tattoo Removal Device
08:00AM  Soliton to Initiate Pivotal Cellulite Trial after Positive Proof-of-Concept Trial Results with 20-47% Improvement in Cellulite Severity Score PR Newswire
07:29AM  Dow Jones Futures Fall: Stock Market Correction Poised To Hit New Lows Investor's Business Daily
May-28-19 05:27PM  Stocks making the biggest moves after hours: Workday, Inovio and more CNBC +148.17%
12:45PM  Soliton Rallies On FDA Approval For Tattoo Removal Device Benzinga
10:19AM  Soliton Receives FDA 510(k) Clearance of its Acoustic Shockwave RAP Device PR Newswire
May-17-19 11:57AM  Soliton Responds To Blog Calling It A 'PR Machine' Benzinga
08:00AM  Soliton Provides FDA Update and Addresses Recent Anonymous Article PR Newswire
May-16-19 08:00AM  Soliton's RAP Device Able to Penetrate Vacuole Shielding; Targets $4 Billion Potential Tattoo Removal Market PR Newswire -31.50%
May-14-19 02:39PM  Biotech Brief: Most Recent Technological Advancements Pushing U.S. Medical Device Market to New Levels PR Newswire -6.94%
08:30AM  Soliton Receives Approval for New Patent for its Acoustic Shockwave Technology PR Newswire
May-13-19 05:05PM  Fighting cellulite and removing tattoos with sound waves Yahoo Finance Video -16.25%
10:31AM  Global market to combat cellulite to reach $1.4B by 2026 Yahoo Finance Video
May-09-19 08:00AM  Soliton to be Featured on Yahoo Finance's 'The First Trade' Show on May 13, 2019 to Discuss Cellulite Trial Results PR Newswire +6.76%
May-01-19 08:00AM  Soliton Announces Completion of New Replaceable Cartridge to Target Cellulite Reduction PR Newswire +6.73%
Apr-23-19 08:00AM  Soliton Announces Global Partner Completes Second Generation RAP Device to More Effectively Target Cellulite Reduction PR Newswire +11.64%
Apr-18-19 08:00AM  Soliton to be Featured on Yahoo Finance's 'The First Trade' Show on May 13, 2019 to Discuss Cellulite Trial Results PR Newswire -9.99%
Apr-15-19 08:00AM  Soliton Announces Cellulite Trial Results to be Presented at National Aesthetics Conference on May 11, 2019 PR Newswire +14.55%
Apr-09-19 08:00AM  Soliton Completes Cellulite Clinical Trials PR Newswire
Apr-04-19 08:00AM  Soliton Receives European Patent for Acoustic Shockwave Technology PR Newswire +11.11%
Apr-01-19 08:00AM  Soliton Initiated Clinical Trials for Treatment of Cellulite in Humans PR Newswire +10.74%
Mar-27-19 08:00AM  Soliton Receives FDA Acceptance for 510(k) Application PR Newswire
Mar-21-19 08:00AM  Soliton Files 510(k) with FDA for its Rapid Acoustic Pulse Device PR Newswire +8.16%
Mar-19-19 08:00AM  Soliton Completes Clinical Trials for Initial FDA Filing for Tattoo Indication PR Newswire +17.55%
Mar-18-19 08:00AM  Soliton to Present at Oppenheimer 29th Annual Healthcare Conference on March 20, 2019 PR Newswire
Mar-14-19 08:00AM  Soliton Partners with Sanmina, a Global Medical Device Manufacturer ACCESSWIRE +10.00%
Mar-12-19 08:00AM  Soliton to Ring the Nasdaq Stock Market Closing Bell on March 19, 2019 ACCESSWIRE
Mar-08-19 08:00AM  Soliton's RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation ACCESSWIRE
Mar-04-19 07:00AM  Soliton Receives FDA Approval for Small Business Designation ACCESSWIRE
Feb-28-19 07:00AM  Soliton Discusses Rapid Acoustic Pulse Technology for Treatment of Cellulite GlobeNewswire +6.85%
Feb-26-19 07:30AM  Soliton Receives Additional Patent for Breakthrough Acoustic Shockwave Technology GlobeNewswire
Feb-19-19 12:03PM  Soliton, Inc. Completes IPO and Begins Trading on Nasdaq Under Ticker Symbol SOLY GlobeNewswire
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. It is developing a product for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.